2015 Nov 05
Has research lost its way?
Harold Varmus, M.D., reflects on the state of research competition and funding. Read more
2015 Nov 05
New drug combination suggests promising treatment for mantle cell lymphoma
Lenalidomide, taken in combination with the antibody Rituximab, provides an effective alternative to chemotherapy, according to findings by Jia Ruan, M.D., Ph.D., John Leonard, M.D., and colleagues. Read more
2015 Nov 05
Vitamin C halts growth of aggressive forms of colorectal cancer in preclinical study
High levels of vitamin C kill colorectal cancers with KRAS and BRAF mutations in cell cultures and mice, according to a new study from Lewis Cantley, Ph.D. Read more
2015 Nov 04
Novel antibodies could revolutionize treatment for relapsed ALL
Coverage of a presentation by Gail Roboz, M.D., at the 33rd Annual Chemotherapy Foundation Symposium Read more
2015 Nov 03
New type of cancer treatment targets proteins in cancer cells
The lab of Ari Melnick, M.D., has developed a new combination Hsp90 inhibition therapy to target diffuse large B-cell lymphoma. Read more
2015 Nov 02
New layer of gene regulation may play key role in common lymphoma
A team of investigators led by Olivier Elemento, Ph.D., has discovered thousands of new genes in 116 human samples of lymphoma. Read more
2015 Nov 02
Genome sequencing of tumors are helping pathologist and physicians identify useful therapies for patients with unresponsive cancers
A recent study by Himisha Beltran, M.D., is highlighted as an example of the promise of precision medicine. Read more
2015 Oct 28
Targeting epigenetic switches may lead to novel therapies for B-cell lymphomas
Coverage of a presentation by Ari Melnick, M.D., at the recent Lymphoma & Myeloma 2015 meeting which featured many Weill Cornell organizers and investigators. Read more
2015 Oct 28
Cell stress response and fat and obesity gene linked
Samie Jaffrey and colleagues have discovered mechanisms that control the function of a fat and obesity gene while also answering a long-standing question about how cells respond to stress. Read more
2015 Oct 28
Tumor exosome protein signatures predict future organ sites of cancer spread
Findings by David Lyden and colleagues support Paget's "seed and soil" theory of metastasis Read more
2015 Oct 28
Clinical, molecular characteristics predict Richter’s syndrome risk factors, outcomes
Coverage of the recent Lymphoma & Myeloma 2015 meeting which featured many Weill Cornell organizers and investigators Read more
2015 Oct 27
Prostate cancer: SPOP the mutation
Christopher Barbieri and colleagues shed light on why prostate tumors with a mutation in a gene called SPOP have a high rearrangement frequency Read more
2015 Oct 27
Second Chance : A Life After Cancer
After surviving pediatric cancer, Frank Paternoster and his family share his deeply moving story. Read more
2015 Oct 27
Prigerson named as NCI Outstanding Investigator
Holly G. Prigerson, Ph.D has been named as a recipient of the NCI Outstanding Investigator Award for her end-of-life care research Read more
2015 Oct 25
Hodgkin lymphoma: Frontline brentuximab monotherapy promising for elderly patients
John P. Leonard, M.D., comments on a single-agent treatment for older patients with Hodgkin lymphoma. Read more
2015 Oct 23
New knowledge of how diseased cells make proteins may have applications to cancer research
Findings from the lab of Samie Jaffrey, Ph.D., about cap-independent translation in the mRNA of diseased cells IDs a novel pathway that could become a therapeutic target. Read more
2015 Oct 22
New insights into telomeres may have implications for cancer therapy
A team led by Neal Lue has discovered vulnerabilities in the ALT pathway that investigators might be able to harness for new targeted cancer therapies. Read more
2015 Oct 22
3-D organoids allow tests of lymphoma treatments
Leandro Cerchetti, Ari Melnick and Ithaca collaborators have created a revolutionary new model to study lymphoma. Read more
2015 Oct 22
Cantley team uncovers vulnerability that can be exploited to kill lung cancer cells
The Cantley lab has gained insight into how alterations in a key metabolic pathway drive non-small cell lung cancers and lead to poor prognosis in its patients. Read more
2015 Oct 22
Skinny Fat
Many normal-sized men and women have hidden inflamed fat just like obese individuals, which can potentially alter the risk of cancer or its progression, according to new studies by Andrew Dannenberg, M.D., and colleagues. Read more
